Adriblastina RD

Adriblastina RD Adverse Reactions

doxorubicin

Manufacturer:

Pfizer

Distributor:

Zuellig
Full Prescribing Info
Adverse Reactions
Adverse reactions reported in association with doxorubicin therapy are listed below by MedDRA System Organ Class and by frequency. Frequencies are defined as: Very common (≥10%), Common (≥1%, <10%), Uncommon (≥0.1%, <1%), Rare (≥0.01%, <0.1%), Very rare (<0.01%), and Not known (cannot be estimated from available data). (See table.)

Click on icon to see table/diagram/image
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in